Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
04/02/1996 | US5503989 Production of peptide amides |
04/02/1996 | US5503978 Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase |
03/28/1996 | WO1996009411A1 Antigen binding peptides (abtides) from peptide libraries |
03/28/1996 | CA2200684A1 Antigen binding peptides (abtides) from peptide libraries |
03/27/1996 | EP0702696A1 Trifunctional antithrombin and antiplatelet peptides |
03/27/1996 | EP0702692A1 Regulation of antigen presentation |
03/27/1996 | EP0702691A1 New thiodepsipeptide isolated from a marine actinomycete |
03/27/1996 | EP0702570A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION |
03/27/1996 | EP0702558A1 Novel opioid peptide inhibitors |
03/27/1996 | CN1119457A Bone stimulating factor |
03/27/1996 | CN1119441A AZA cyclohexapeptide compounds |
03/26/1996 | US5502036 Viricides |
03/26/1996 | US5502035 Hormone inhibitors |
03/26/1996 | US5502033 Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases |
03/26/1996 | US5502032 Peptides, the preparation and use thereof |
03/21/1996 | WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
03/21/1996 | WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
03/21/1996 | WO1996008509A1 Anti-fungal peptides |
03/21/1996 | WO1996008507A1 Aza cyclohexapeptide compounds |
03/21/1996 | WO1996008506A1 Phosphorus-32 labeling of antibodies for cancer therapy |
03/21/1996 | WO1996008275A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
03/21/1996 | WO1996008267A1 Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use |
03/21/1996 | WO1996008266A1 Aza cyclohexapeptide compounds |
03/21/1996 | WO1996008264A1 Synthetic antibiotics |
03/21/1996 | DE4433479A1 Proteins isolated from Boophilus microplus |
03/21/1996 | CA2200088A1 Phosphorus-32 labeling of antibodies for cancer therapy |
03/21/1996 | CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
03/21/1996 | CA2199746A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
03/20/1996 | EP0701818A2 Therapeutic methods using catalytic antibodies |
03/20/1996 | EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
03/20/1996 | EP0701448A1 Amplification of the vitamin b 12? uptake system using polymers |
03/20/1996 | EP0701447A1 Cyclohexapeptidyl propanolamine compounds |
03/20/1996 | EP0449973B1 Polypeptide-polymer conjugates active in wound healing |
03/20/1996 | CN1031344C Process for preparing peptides inhibiting maturation of T-lymphocytes and activity of macrophages |
03/19/1996 | US5500414 Derivatives of peptides usable as inhibitors of bacterial collagenases |
03/19/1996 | US5500413 Process for manufacture of 1-deamino-8-D-arginine vasopressin |
03/19/1996 | CA1338171C Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical |
03/14/1996 | WO1996007754A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
03/14/1996 | WO1996007671A1 Racemization-free preparation of n-amino acid derivatives and dipeptides |
03/14/1996 | WO1995035376A3 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
03/13/1996 | EP0700998A1 Recombinant mersacidin and a method for production |
03/13/1996 | EP0700430A1 Methods for selectively stimulating proliferation of t cells |
03/13/1996 | EP0700302A1 Method of treating diabetes mellitus |
03/13/1996 | EP0700301A1 Peptides and compounds that bind to elam-1 |
03/13/1996 | EP0491007B1 Structural alterations of the egf receptor gene in human gliomas |
03/13/1996 | EP0436545B1 Therapeutic methods using catalytic antibodies |
03/13/1996 | EP0428602B1 Polypeptides and dna encoding same |
03/13/1996 | CN1118601A Inhibitors of herpes viral ribonucleotide reductase |
03/13/1996 | CN1118573A Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
03/13/1996 | CN1118572A HLA-A2.1 combined peptide and application of same |
03/13/1996 | CN1031242C 化妆品组合物 Cosmetic composition |
03/12/1996 | US5498601 Rgd sequence |
03/07/1996 | WO1996006857A1 Immunostimulatory agents |
03/07/1996 | WO1996006630A1 Methods and compositions for modulating a t cell response |
03/07/1996 | WO1996006619A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
03/07/1996 | DE4431513A1 Racemisierungsfreie Herstellung und Verwendung von N-Methoxy- oder -Hydroxy-benzyl-Aminosäurederivaten und -Dipeptiden Racemization preparation and use of N-methoxy-benzyl or hydroxy-protected dipeptides and amino acid derivatives |
03/07/1996 | CA2198348A1 Analgesic method with dynorphin analogues truncated at the n-terminus |
03/06/1996 | EP0699209A1 PROCESSES AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS |
03/06/1996 | EP0699208A1 Novel peptide nucleic acids |
03/06/1996 | EP0476059B1 Methods for enhancing the rate of modification of metastable bonds |
03/06/1996 | EP0449955B1 Synthetic hiv-like peptides, their compositions and uses |
03/06/1996 | CN1031193C Polypeptide and method for preparing same |
03/05/1996 | US5496938 Nucleic acid ligands to HIV-RT and HIV-1 rev |
03/05/1996 | US5496724 Genes encoding platelet aggregation inhibitors |
03/05/1996 | US5496551 Polypeptide immunogens |
02/29/1996 | WO1996006353A1 Lysine/leucine polypeptides, mixture sets and libraries thereof |
02/29/1996 | WO1996006111A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
02/29/1996 | WO1996006109A1 An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides |
02/29/1996 | WO1996005858A1 Haemophilus adherence and penetration proteins |
02/29/1996 | CA2197562A1 Haemophilus adherence and penetration proteins |
02/29/1996 | CA2197242A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
02/28/1996 | EP0698614A1 Endothelin-antagonizing peptide |
02/28/1996 | EP0698613A1 Endothelin-antagonizing peptide |
02/28/1996 | EP0698103A1 CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE |
02/28/1996 | EP0698101A1 Hepatitis-c virus type 4, 5 and 6 |
02/28/1996 | EP0698091A1 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
02/28/1996 | EP0698089A1 Nucleic acid encoding amp-activated protein kinase |
02/28/1996 | EP0698040A1 Lhrh antagonists |
02/28/1996 | EP0698039A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock |
02/28/1996 | EP0697888A1 Conserved motif of hepatitis c virus e2/ns1 region |
02/28/1996 | EP0697879A1 Cyclohexapeptidyl aminoalkyl ethers |
02/28/1996 | EP0362367B1 Osteogenic devices |
02/27/1996 | US5495000 Anticoagulant peptides |
02/27/1996 | US5494999 For assaying, purifying or inducing cdw52 antibody |
02/27/1996 | US5494893 Stylostatin 2 |
02/27/1996 | US5494809 Culturing and incubating cells of bacillus amyloliquefaciens |
02/27/1996 | US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence |
02/27/1996 | US5494679 Molecules for iontophoretic delivery |
02/27/1996 | US5494672 Pseudomonas peptide composition and method |
02/22/1996 | WO1996005221A1 Calcitonin receptor |
02/22/1996 | WO1996005220A1 Compounds for use in treatment of carcinomas |
02/22/1996 | WO1996005219A1 Purified form of streptogramines, preparation thereof and pharmaceutical compositions containing it |
02/22/1996 | WO1996005218A1 Delivery of nucleic acids |
02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
02/22/1996 | WO1996004927A1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF |
02/22/1996 | WO1996004926A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ η1 CHAIN |
02/22/1996 | DE4418691A1 3'-(4'-) nicht-radioaktiv markierte Nukleoside und Nukleotide mit Aminocarbonsäure-, Peptid- oder Carbonsäure-Spacer 3 '- (4') non-radioactively labeled nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid-spacer |
02/22/1996 | CA2196053A1 Two non-contiguous regions contribute to nidogen binding to a single egf-like motif of the laminin .gamma.1 chain |
02/22/1996 | CA2173727A1 Novel gnrh analogues with antitumour effects and pharmaceutical compositions thereof |
02/21/1996 | EP0696919A1 Diagnosis and treatment of erectile dysfunction |